XML 59 R6.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statement of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Balance (in shares) at Sep. 30, 2018   32,774,118      
Balance at Sep. 30, 2018 $ 129,654 $ 33 $ 236,115 $ (6,449) $ (100,045)
Increase (Decrease) in Stockholders' Equity          
Net loss (5,022)       (5,022)
Exercise of stock options, grants of restricted stock awards, and vesting of restricted stock units (in shares)   409,060      
Exercise of stock options, grants of restricted stock awards, and vesting of restricted stock units             8   8    
Balance (in shares) at Dec. 31, 2018   33,183,178      
Balance at Dec. 31, 2018 126,499 $ 33 237,679 (6,876) (104,337)
Balance (in shares) at Sep. 30, 2018   32,774,118      
Balance at Sep. 30, 2018 129,654 $ 33 236,115 (6,449) (100,045)
Increase (Decrease) in Stockholders' Equity          
Net loss (9,384)        
Foreign currency translation (229)        
Balance (in shares) at Mar. 31, 2019   33,347,657      
Balance at Mar. 31, 2019 124,465 $ 33 239,806 (6,678) (108,696)
Balance (in shares) at Dec. 31, 2018   33,183,178      
Balance at Dec. 31, 2018 126,499 $ 33 237,679 (6,876) (104,337)
Increase (Decrease) in Stockholders' Equity          
Net loss (4,362)       (4,362)
Exercise of stock options, grants of restricted stock awards, and vesting of restricted stock units (in shares)   197,642      
Exercise of stock options, grants of restricted stock awards, and vesting of restricted stock units             116   116    
Forfeitures of restricted stock awards 0        
Foreign currency translation 198        
Balance (in shares) at Mar. 31, 2019   33,347,657      
Balance at Mar. 31, 2019 124,465 $ 33 239,806 (6,678) (108,696)
Balance (in shares) at Sep. 30, 2019   33,687,115      
Balance at Sep. 30, 2019 116,175 $ 34 242,686 (7,973) (118,572)
Increase (Decrease) in Stockholders' Equity          
Net loss (5,196)       (5,196)
Exercise of stock options, grants of restricted stock awards, and vesting of restricted stock units (in shares)   283,164      
Exercise of stock options, grants of restricted stock awards, and vesting of restricted stock units             2   2    
Taxes paid associated with net settlement of stock compensation awards (in shares)   (67,688)      
Taxes paid associated with net settlement of stock compensation awards (498)   (498)    
Forfeitures of restricted stock awards (in shares)   (15,000)      
Forfeitures of restricted stock awards 0        
Stock compensation expense 1,121   1,121    
Foreign currency translation 833     833  
Balance (in shares) at Dec. 31, 2019   33,887,591      
Balance at Dec. 31, 2019 112,437 $ 34 243,311 (7,140) (123,768)
Balance (in shares) at Sep. 30, 2019   33,687,115      
Balance at Sep. 30, 2019 116,175 $ 34 242,686 (7,973) (118,572)
Increase (Decrease) in Stockholders' Equity          
Net loss (9,434)        
Foreign currency translation (470)        
Balance (in shares) at Mar. 31, 2020   33,988,798      
Balance at Mar. 31, 2020 108,112 $ 34 244,527 (8,443) (128,006)
Balance (in shares) at Dec. 31, 2019   33,887,591      
Balance at Dec. 31, 2019 112,437 $ 34 243,311 (7,140) (123,768)
Increase (Decrease) in Stockholders' Equity          
Net loss (4,238)       (4,238)
Exercise of stock options, grants of restricted stock awards, and vesting of restricted stock units (in shares)   111,272      
Exercise of stock options, grants of restricted stock awards, and vesting of restricted stock units             32   32    
Taxes paid associated with net settlement of stock compensation awards (in shares)   (10,065)      
Taxes paid associated with net settlement of stock compensation awards (60)   (60)    
Stock compensation expense 1,244   1,244    
Foreign currency translation (1,303)     (1,303)  
Balance (in shares) at Mar. 31, 2020   33,988,798      
Balance at Mar. 31, 2020 $ 108,112 $ 34 $ 244,527 $ (8,443) $ (128,006)